Polyfunctional Melan-A-specific tumor-reactive CD8+T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polyfunctional Melan-A-specific tumor-reactive CD8+T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 5, Pages e1114203
Publisher
Informa UK Limited
Online
2016-02-02
DOI
10.1080/2162402x.2015.1114203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+T-cell proliferation and survival
- (2015) Rasha Abu Eid et al. OncoImmunology
- Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
- (2014) A. B. van der Waart et al. BLOOD
- Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
- (2014) J. G. Crompton et al. CANCER RESEARCH
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
- (2014) Xiaozhou Fan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Predicting the Impact of CD8+ T Cell Polyfunctionality on HIV Disease Progression
- (2014) F. Graw et al. JOURNAL OF VIROLOGY
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Sprouty-2 regulates HIV-specific T cell polyfunctionality
- (2013) Yen-Ling Chiu et al. JOURNAL OF CLINICAL INVESTIGATION
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- ICOS Regulates the Generation and Function of Human CD4+ Treg in a CTLA-4 Dependent Manner
- (2013) Jian Zheng et al. PLoS One
- Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells
- (2013) Amandine Legat et al. Frontiers in Immunology
- Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy
- (2012) Z.-C. Ding et al. BLOOD
- Signal Integration by Akt Regulates CD8 T Cell Effector and Memory Differentiation
- (2012) E. H. Kim et al. JOURNAL OF IMMUNOLOGY
- Interferon-α as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature
- (2012) Eleonora Aricò et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
- (2012) Lukas Baitsch et al. PLoS One
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose
- (2011) Tanja Lövgren et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism
- (2011) Andrew N. Macintyre et al. IMMUNITY
- Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade
- (2011) Sian M. Henson et al. IMMUNOLOGY
- Clonotype and Repertoire Changes Drive the Functional Improvement of HIV-Specific CD8 T Cell Populations under Conditions of Limited Antigenic Stimulation
- (2011) L. Janbazian et al. JOURNAL OF IMMUNOLOGY
- Phenotype, Function, and Gene Expression Profiles of Programmed Death-1 hi CD8 T Cells in Healthy Human Adults
- (2011) Jaikumar Duraiswamy et al. JOURNAL OF IMMUNOLOGY
- Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A-Specific, Tumor-Reactive CTL in Melanoma Patients
- (2010) B. Palermo et al. CANCER RESEARCH
- Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells
- (2010) N. Martin-Orozco et al. CANCER RESEARCH
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
- (2010) Rachel H. McMahan et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of CD27/CD70 pathway of activation in immunity and tolerance
- (2010) Julie Denoeud et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers
- (2010) M. Ayyoub et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
- (2009) S. M. Henson et al. BLOOD
- Inducible Costimulator (ICOS) Enhances the Cytolytic Activity of Cytokine-Induced Killer Cells Against Gallbladder CancerIn VitroandIn Vivo
- (2009) Jian Wang et al. CANCER INVESTIGATION
- Impaired CD4 and CD8 Effector Function and Decreased Memory T Cell Populations in ICOS-Deficient Patients
- (2009) N. Takahashi et al. JOURNAL OF IMMUNOLOGY
- Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
- (2008) Paola Nisticò et al. INTERNATIONAL JOURNAL OF CANCER
- Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells
- (2008) G. Badr et al. JOURNAL OF VIROLOGY
- AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition
- (2008) S. Caporali et al. MOLECULAR PHARMACOLOGY
- CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
- (2008) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started